Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.

A hidden benefit of this new approach is its environmental alignment. When Schneider Electric built a multi-tier AI twin for ...